MGC Diagnostics Corporation (NASDAQ:MGCD) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
Results for Fiscal Year ended October 31, 2016
On January 25, 2017, MGC Diagnostics Corporation (the Company)
issued a press release announcing its results for the fiscal 2016
fourth quarter and year ended October 31, 2016. A copy of the
press release is furnished as Exhibit 99.1 to this Form 8-K.
The information provided to Item 2.02 of this Form 8-K is being
furnished and is not filed for purposes of Section 18 of the
Securities Act of 1934, and may not be deemed incorporated by
reference in any filing under the Securities Act of 1933, except
as expressly set forth by specific reference in that filing.
Section 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following is furnished as an Exhibit to this Report:
| Exhibit No. | Description of Exhibit | |
| 99.1 |
Press release dated January 25, 2017, reporting results for the fiscal 2016 fourth quarter and fiscal year ended October 31, 2016. |
About MGC Diagnostics Corporation (NASDAQ:MGCD)
MGC Diagnostics Corporation is a medical technology company. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. The Company operates in the manufacture and sale of cardiorespiratory diagnostic products segment. The Company’s product portfolio provides solutions for disease detection, integrated care, and wellness across the cardiorespiratory healthcare range. The Company sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals and university-based medical centers, among others. The Company’s cardiorespiratory diagnostic products measure flow and respiratory pressures and also analyzes the inhaled and exhaled gases, such as oxygen and carbon dioxide. The Company offers its products in various categories, such as Pulmonary Function Products (PFT), Gas Exchange Testing Products, Cycle Ergometers and Treadmills, and Electronic Medical Records Interfaces. MGC Diagnostics Corporation (NASDAQ:MGCD) Recent Trading Information
MGC Diagnostics Corporation (NASDAQ:MGCD) closed its last trading session up +0.69 at 7.89 with 1,675 shares trading hands.
